Sign In

Minnie Sarwal

Professor, UCSF, Stanford; Founder, Nephrosant, Inc.

Dr. Minnie Sarwal is a prominent nephrologist, researcher, and professor at the University of California, San Francisco (UCSF). Here are some key details about her background and accomplishments:

Education and Training

Dr. Sarwal received her medical degree from Calcutta National Medical College in India.1 She went on to obtain additional qualifications in the UK, including:

  • Diploma in Child Health (DCH) from London University
  • Membership of the Royal College of Physicians (MRCP) in 1990
  • PhD in Molecular Genetics from Cambridge University in 19952

Current Position

She currently serves as:

  • Professor in Residence of Surgery at UCSF
  • Director of the Precision Transplant Medicine Initiative at UCSF24

Areas of Expertise

Dr. Sarwal specializes in:

  • Adult and pediatric nephrology
  • Transplant immunology
  • Kidney and pancreas transplantation
  • Acute and chronic renal failure
  • Glomerular disease12

Research and Innovations

She has made significant contributions to the field of organ transplantation, including:

  • Conducting the first successful complete steroid avoidance trial in the US for kidney transplants
  • Pioneering genomic and proteomic investigations into organ transplant injury mechanisms
  • Developing blood tests for early diagnosis of kidney transplant rejection2

Entrepreneurship

Dr. Sarwal has founded multiple biotechnology companies:

  • Organ-i in 2009 (acquired by Immucor in 2014)
  • NephroSant, where she serves as Chief Medical Officer23

Academic Achievements

  • Author of over 290 scientific publications
  • Inventor on over 20 patents
  • Editor of handbooks and journals in nephrology and transplantation2

Awards and Recognition

  • Cuneo Richardson Award for outstanding contributions to kidney disease research
  • TTS-Roche award for excellence in clinical translational science in organ transplantation2

Dr. Sarwal's work spans clinical care, research, and innovation in nephrology and transplantation, making her a leading figure in the field.

Highlights

Jan 3 · PRNewswire
NephroSant Features QSant, the first urine test for kidney transplant rejection, at Biotech Showcase Digital 2022 - PRNewswire
Jan 3 · Yahoo Finance
NephroSant Features QSant, the first urine test for kidney transplant rejection, at Biotech Showcase Digital 2022 - Yahoo Finance

Related Questions

What are some of Dr. Minnie Sarwal's most notable achievements in nephrology?
How has Dr. Minnie Sarwal's work impacted kidney transplantation?
What is the Precision Transplant Medicine Initiative at UCSF?
Can you provide more details about Dr. Sarwal's research on transplant immunology?
What are the key findings from Dr. Sarwal's genomic and proteomics investigations?
Minnie Sarwal
Minnie Sarwal, photo 1
Minnie Sarwal, photo 2
Add to my network

Location

San Francisco Bay Area